Structural and Functional Nerve Changes Following Immobilisation After Distal Radius Fracture - a Pilot Study (NRP) (NRP)

May 7, 2025 updated by: University of Tromso

Immobilization after radius fracture seems to increase the risk of developing a Complex regional pain syndrome (CRPS), a condition associated with pain, increased skin sensitivity and reduced epidermal nerve density.

The purpose of the study is to determine whether 5-week immobilisation leads to functional and structural sensory changes, and whether the changes are associated with persistent pain. The investigators plan an explorative, pilot study on six consenting patients immobilised after a distal radius fracture.

The baseline measurements will be recorded at the day of or the day after trauma: Demographics, psychological and physical comorbidity, pain characteristics and intensity, hand function, health related quality of life (HRQOL), quantitative sensory testing will be recorded while skin biopsies are analyzed for epidermal nerve fiber density. Following variables such as pain characteristics and intensity, hand function, health related quality of life, quantitative sensory testing and skin biopsies will be reassessed when the cast is removed and two months later.

Study Overview

Status

Withdrawn

Intervention / Treatment

Detailed Description

Distal radius fracture is a prevalent injury, affecting 15.000 cases in Norway every year. About 5% of these patients suffer from longlasting pain and some develop a serious and chronic CRPS. Patients subjected to hand surgery frequently report pain one month after cast removal, and further examinations have revealed vascular and trophic changes, and increased sensitivity to pressure and cold as well as elevated skin levels of proinflammatory mediators.

Long term immobilization seems to increase the risk of developing CRPS symptoms. In a Danish study healthy volunteers demonstrated increased hyperalgesia to cold and mechanical stimuli even after 4-week immobilization which may indicate an early change in the nerve function.

In CRPS patients skin biopsies have demonstrated reduced epidermal nerve fiber density, but such data are lacking after radius fracture and during early stage of CRPS.

The purpose of this explorative, observational, pilot study is to investigate whether radius fracture followed by 5-week of immobilization, leads to functional and structural changes of the sensory system which are reversed after remobilization and whether the sensory changes are associated with persistent pain.

Our hypotheses are: 1) Patients with an immobilised arm following a radius fracture develops a) early cutaneous hypersensitivity (hyperalgesia and allodynia) for mechanical og thermal stimuli and b) reduced epidermal nerve fiber density.

2) The changes of the sensory system are reversed after 2-month remobilization. 3) The functional and structural changes are correlated with patient reported outcome measures (PROM) such as disability of arm, shoulder and hand (DASH), with pain intensity (NRS), duration of the pain and HRQOL .

Eligible patients will be included throughout 2015, and results will be analyzed within December 2015.

Measurements:

Self reported: Demographics (age, gender, civil state, education, working status, social security benefits) and clinical data of comorbidity, pain characteristics (DN4) and intensity (NRS), blood pressure, smoking /other kind of nicotine use, pain medication, and assessment scales for mental distress (HSCL 25), pain catastrophizing (PCS), hand function (DASH), and HRQOL (EQ5D).

Examinations: Quantitative sensory testing (tactile and thermal stimuli) and skin biopsies are carried out 10 cm proximal to fracture line on the dorsum of the affected arm. Measurements for predictor analyses will only be performed at baseline while outcome measurements will be performed prior to and just after removal of the cast as well as two months later.

Statistical analyses:

Regression analyses will be performed to identify other predictors for the changes in sensory nervous system including blood pressure, smoking /other kind of nicotine use, medication, age, gender, and comorbidity. Longitudinal analyses of numerical outcome (ANOVA repeated measurement) will be carried out for outcome measurements such as pain intensity,hand function, HRQOL, sensory thresholds and epidermal nerve fiber density.

Study Type

Observational

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tromso, Norway, 9019
        • University Hospital of North Norway

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients referred to the Emergency Clinic at The University Hospital in North Norway Tromso day time

Description

Inclusion Criteria:

  • Consent competence
  • Acute stable distal radius fracture (less than 48 hours)
  • Allocated to conservative treatment with 5-week immobilization

Exclusion Criteria:

  • Comorbidity which may prevent completion of the study
  • Serious and progressive disease
  • Chronic shoulder disease with limited ROM and function.
  • Sign peripheral nerve injury in the upper extremities
  • Polyneuropathy
  • Demyelination disease
  • Diabetes mellitus
  • Anticoagulants including acetyl salicylic acid (ASA)
  • Allergy to local anesthetics

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from baseline in nerve fiber density at five weeks
Time Frame: From baseline to five weeks after injury
ANOVA repeated measurements based on repeated skin biopsies
From baseline to five weeks after injury
Changes from baseline in sensitivity to thermal and tactile stimuli at five weeks
Time Frame: From baseline to five weeks after injury
ANOVA repeated measurements based on repeated sensory quantitative testing
From baseline to five weeks after injury

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes from five weeks in nerve fiber density at 13 weeks
Time Frame: From five weeks to 13 weeks after injury
ANOVA repeated measurements based on results from repeated skin biopsies
From five weeks to 13 weeks after injury
Changes from five weeks in sensitivity to thermal and tactile stimuli at 13 weeks
Time Frame: From five to 13 weeks after injury
ANOVA repeated measurements based on sensory quantitative testing
From five to 13 weeks after injury
Correlation between changes in pain intensity and changes in nerve fiber density
Time Frame: From baseline to 13 weeks
Statistical regression analyses based on repeated assessments of self reported pain intensity and skin biopsies
From baseline to 13 weeks
Correlation between changes in pain intensity and changes in sensitivity to thermal and tactile stimuli
Time Frame: From baseline to 13 weeks
Statistical regression analyses based on repeated assessments of self reported pain intensity and quantitative sensory testing
From baseline to 13 weeks
Changes from baseline (preinjury) in disability of arm, shoulder and hand are correlated with changes in pain intensity at five and 13 weeks
Time Frame: From baseline to 13 weeks
Statistical regression analyses based on repeated self reports of pain intensity and DASH
From baseline to 13 weeks
Changes from baseline (preinjury) HRQOL are correlated with changes in pain intensity at five and 13 weeks
Time Frame: From baseline to 13 weeks
Statistical regression analyses based on repeated self reports of pain intensity and HRQOL (EQ5D)
From baseline to 13 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Gunnvald Kvarstein, PhD, University of Tromso

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

May 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

December 1, 2028

Study Registration Dates

First Submitted

March 17, 2015

First Submitted That Met QC Criteria

March 23, 2015

First Posted (Estimated)

March 24, 2015

Study Record Updates

Last Update Posted (Actual)

May 13, 2025

Last Update Submitted That Met QC Criteria

May 7, 2025

Last Verified

May 1, 2025

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Distal Radius Fracture

Clinical Trials on Immobilization

Subscribe